Testing STI screening to improve HIV prevention medication use during pregnancy

This trial is testing whether adding regular sexually transmitted infection (STI) screening to HIV prevention care helps pregnant women stick with taking PrEP — a daily medication that prevents HIV infection. Researchers are enrolling 600 pregnant women without HIV in Botswana to see if this combined approach improves how often women take the medication and whether they continue using it after giving birth.

Many pregnant women who start HIV prevention medication stop taking it or don't use it consistently. Researchers believe that combining this medication with regular STI testing and treatment might help women stay more engaged with their care and continue protecting themselves throughout pregnancy and after delivery.